A person's 'bioenergetic age' -- or how youthfully their cells generate energy -- might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research shows. The study ...

Scientists have discovered that how well a person’s cells generate energy—what they call “bioenergetic age”—could be a strong ...

Researchers have discovered that a person's "bioenergetic age," reflecting how efficiently cells produce energy, strongly ...

Notably, microglia spatially associated with amyloid plaques exhibited increased expression of TREM2 and ApoE compared to such cells in non-immunized controls, regardless of whether the treatment was ...

A person's "bioenergetic age"—or how youthfully their cells generate energy—might be a key indicator of whether they're at risk of developing ...

Alzheimer’s research requires studies that can last for decades, said Dr. Thomas Grabowski, the center’s director and a professor of radiology and neurology at the UW School of Medicine. Those studies ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...

I am very happy and proud. It feels both exciting and honorable to receive this prize, says Lars Lannfelt, professor emeritus at Uppsala University and one of BioArctic's two founders. I am very happy ...

While researchers continue to work on a full cure for Alzheimer's disease, they're finding treatments that can help manage ...

Not the Same. In amyloid-negative people (left) few tangles accumulate over a decade. In amyloid-positives (right), tangles grow faster in women (red) than men (blue). [Courtesy of Gillian Coughlan, ...

AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...